Second-Half Slump Pulls Genomics Stocks Down Sharply in 2011 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A strong first half of the year for the GenomeWeb Daily News Index eroded over the back half of 2011 as the stock prices of many genomics tools and some molecular diagnostics vendors fell amid challenging market conditions.

Driving the slide in the genomics tools sector has been uncertainty surrounding public funding sources for research and a slowdown among some customer end markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.